Glenmark’s Trandolapril is an angiotensin converting enzyme inhibitor used to treat high blood pressure and is the generic equivalent of Mavik tablets marketed by Abbott Laboratories.
This recent approval coupled with the three abbreviated new drug application approvals received from the FDA in May 2008 for Mometasone cream USP 0.1%, Mometasone ointment USP 0.1% and Metformin tablets USP 500mg, 850mg, 1000mg brings Glenmark’s current portfolio to 33 generic products authorized for distribution in the US market.